Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Biogen Inc. BIIB

Full chart Compare
Set alert

Price alert · BIIB

All alert types
254.46 USD +5.53 (+2.22%)

At closeNov 4, 2026, 5:04 PM EST

254.46 0.00 0.00%

After hours · Nov 4, 5:04 PM ET

246.49 Day range 255.35
148.51 52-week range 258.78
YTD
+44.59%
1 year
+70.40%

Financial health

Altman Z-Score

3.11 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B3 / 5 overall

  • DCF 4
  • Return on Equity 2
  • Return on Assets 3
  • Debt / Equity 2
  • P/E 1
  • P/B 4

Valuation

P/E 19.9×
FY 2016: 16.7×FY 2017: 26.7×FY 2018: 13.9×FY 2019: 9.4×FY 2020: 9.8×FY 2021: 23.0×FY 2022: 13.2×FY 2023: 32.3×FY 2024: 13.7×FY 2025: 19.9×
FY 2016 5y median 19.9× FY 2025
P/S 2.6×
FY 2016: 5.4×FY 2017: 5.5×FY 2018: 4.6×FY 2019: 3.9×FY 2020: 2.9×FY 2021: 3.3×FY 2022: 4.0×FY 2023: 3.8×FY 2024: 2.3×FY 2025: 2.6×
FY 2016 5y median 3.3× FY 2025
P/B 1.4×
FY 2016: 5.1×FY 2017: 5.4×FY 2018: 4.7×FY 2019: 4.2×FY 2020: 3.7×FY 2021: 3.3×FY 2022: 3.0×FY 2023: 2.5×FY 2024: 1.3×FY 2025: 1.4×
FY 2016 5y median 2.5× FY 2025
P/FCF 12.6×
FY 2016: 16.0×FY 2017: 18.4×FY 2018: 11.6×FY 2019: 8.5×FY 2020: 10.4×FY 2021: 10.6×FY 2022: 35.2×FY 2023: 30.3×FY 2024: 8.9×FY 2025: 12.6×
FY 2016 5y median 12.6× FY 2025
EV/EBITDA 10.1×
FY 2016: 10.3×FY 2017: 10.9×FY 2018: 9.5×FY 2019: 7.6×FY 2020: 9.0×FY 2021: 10.5×FY 2022: 12.3×FY 2023: 18.4×FY 2024: 8.9×FY 2025: 10.1×
FY 2016 5y median 10.5× FY 2025
EV/Sales 3.0×
FY 2016: 5.8×FY 2017: 5.9×FY 2018: 4.9×FY 2019: 4.1×FY 2020: 3.4×FY 2021: 3.7×FY 2022: 4.3×FY 2023: 4.4×FY 2024: 2.7×FY 2025: 3.0×
FY 2016 5y median 3.7× FY 2025
FCF Yield 7.9%
FY 2016: 6.2%FY 2017: 5.4%FY 2018: 8.6%FY 2019: 11.8%FY 2020: 9.7%FY 2021: 9.5%FY 2022: 2.8%FY 2023: 3.3%FY 2024: 11.3%FY 2025: 7.9%
FY 2016 5y median 7.9% FY 2025

Profitability

Gross Margin 70.5%
FY 2016: 87.5%FY 2017: 86.7%FY 2018: 86.5%FY 2019: 86.4%FY 2020: 86.6%FY 2021: 80.8%FY 2022: 77.6%FY 2023: 74.2%FY 2024: 76.1%FY 2025: 70.5%
FY 2016 5y median 76.1% FY 2025
Operating Margin 19.1%
FY 2016: 45.0%FY 2017: 43.6%FY 2018: 43.8%FY 2019: 49.0%FY 2020: 34.2%FY 2021: 25.4%FY 2022: 28.4%FY 2023: 21.3%FY 2024: 25.7%FY 2025: 19.1%
FY 2016 5y median 25.4% FY 2025
Net Margin 13.2%
FY 2016: 32.3%FY 2017: 20.7%FY 2018: 32.9%FY 2019: 41.0%FY 2020: 29.8%FY 2021: 14.2%FY 2022: 29.9%FY 2023: 11.8%FY 2024: 16.9%FY 2025: 13.2%
FY 2016 5y median 14.2% FY 2025
ROE 7.1%
FY 2016: 30.5%FY 2017: 20.1%FY 2018: 34.0%FY 2019: 44.1%FY 2020: 37.4%FY 2021: 14.3%FY 2022: 22.7%FY 2023: 7.8%FY 2024: 9.8%FY 2025: 7.1%
FY 2016 5y median 9.8% FY 2025
ROIC 6.6%
FY 2016: 19.8%FY 2017: 13.7%FY 2018: 20.3%FY 2019: 24.7%FY 2020: 17.7%FY 2021: 13.2%FY 2022: 11.2%FY 2023: 8.0%FY 2024: 8.8%FY 2025: 6.6%
FY 2016 5y median 8.8% FY 2025
ROA 4.4%
FY 2016: 16.2%FY 2017: 10.7%FY 2018: 17.5%FY 2019: 21.6%FY 2020: 16.3%FY 2021: 6.5%FY 2022: 12.4%FY 2023: 4.3%FY 2024: 5.8%FY 2025: 4.4%
FY 2016 5y median 5.8% FY 2025

Growth (YoY)

Revenue 1.4%
FY 2016: 6.4%FY 2017: 7.2%FY 2018: 9.6%FY 2019: 6.9%FY 2020: -6.5%FY 2021: -18.3%FY 2022: -7.4%FY 2023: -3.3%FY 2024: -1.6%FY 2025: 1.4%
FY 2016 FY 2025
Operating Income -24.6%
FY 2016: 5.3%FY 2017: 3.8%FY 2018: 10.2%FY 2019: 19.6%FY 2020: -34.8%FY 2021: -39.2%FY 2022: 3.5%FY 2023: -27.4%FY 2024: 18.7%FY 2025: -24.6%
FY 2016 FY 2025
EPS (diluted) -21.1%
FY 2016: 10.4%FY 2017: -29.6%FY 2018: 81.0%FY 2019: 45.6%FY 2020: -21.1%FY 2021: -58.1%FY 2022: 100.7%FY 2023: -61.8%FY 2024: 40.4%FY 2025: -21.1%
FY 2016 FY 2025
Free Cash Flow -18.5%
FY 2016: 25.6%FY 2017: -4.6%FY 2018: 43.9%FY 2019: 23.8%FY 2020: -42.0%FY 2021: -11.1%FY 2022: -66.2%FY 2023: 8.0%FY 2024: 103.6%FY 2025: -18.5%
FY 2016 FY 2025

Financial Health

Current Ratio 2.7×
FY 2016: 2.6×FY 2017: 2.3×FY 2018: 2.3×FY 2019: 1.7×FY 2020: 1.8×FY 2021: 1.8×FY 2022: 3.0×FY 2023: 2.0×FY 2024: 1.3×FY 2025: 2.7×
FY 2016 5y median 2.0× FY 2025
Quick Ratio 2.0×
FY 2016: 2.3×FY 2017: 2.1×FY 2018: 2.0×FY 2019: 1.6×FY 2020: 1.6×FY 2021: 1.5×FY 2022: 2.6×FY 2023: 1.3×FY 2024: 0.9×FY 2025: 2.0×
FY 2016 5y median 1.5× FY 2025
Debt / Equity 0.4×
FY 2016: 0.5×FY 2017: 0.5×FY 2018: 0.5×FY 2019: 0.5×FY 2020: 0.7×FY 2021: 0.7×FY 2022: 0.5×FY 2023: 0.5×FY 2024: 0.4×FY 2025: 0.4×
FY 2016 5y median 0.5× FY 2025
Net Debt / EBITDA 1.3×
FY 2016: 0.7×FY 2017: 0.7×FY 2018: 0.7×FY 2019: 0.4×FY 2020: 1.3×FY 2021: 1.4×FY 2022: 0.9×FY 2023: 2.6×FY 2024: 1.4×FY 2025: 1.3×
FY 2016 5y median 1.4× FY 2025
Interest Coverage 7.6×
FY 2016: 19.8×FY 2017: 21.3×FY 2018: 29.4×FY 2019: 37.6×FY 2020: 20.6×FY 2021: 11.0×FY 2022: 11.7×FY 2023: 8.5×FY 2024: 9.9×FY 2025: 7.6×
FY 2016 5y median 9.9× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31